Latest News

Filters

Filter by tags: United States South Korea Europe Clear all tag filters

30 news articles found


Czech power utility CEZ Group's Elektrárna Dukovany II (EDU II), a wholly owned subsidiary has received three final bids for the construction of a new unit at the Dukovany NPP. US-based Westinghouse, France’s EDF and Korea Hydro & Nuclear Power (KHNP) submitted binding bids for Dukovany 5 and non-binding bids for the other three units. Westinghouse is proposing its AP1000, KHNP its APR1000 based in the APR1400 and EDF its EPR1200 (a smaller version of its standard EPR). These are all pressurised water reactors. Russia and China were excluded from the bidding in 2021.

Date: Friday, 03 November 2023
Original article: neimagazine.com/news/newsfinal-bids-submitted-for-new-dukovany-npp-units-11265668

ČEZ subsidiary Elektrárna Dukovany II (EDU II) has received final bids from the three potential suppliers for a new nuclear unit at Dukovany, as well as non-binding offers for three more future reactors.

Date: Wednesday, 01 November 2023
Original article: world-nuclear-news.org/Articles/Westinghouse,-EDF-and-KHNP-submit-final-Czech-bids

A Memorandum of Understanding (MOU) has been signed by Romanian nuclear utility Societatea Na?ionala Nuclearelectrica (SNN), US-based NuScale Power, Romanian companies E-INFRA and Nova Power & Gas, US-based Fluor Enterprises and South Korea’s Samsung C&T Corporation to collaborate in the deployment of NuScale VOYGR Power Plants in Central and Eastern Europe and in Romania.

Date: Friday, 16 June 2023
Original article: neimagazine.com/news/newscompanies-collaborate-to-promote-nuscale-smrs-in-central-and-eastern-europe-10943608

Nuclearelectrica, E-INFRA, Nova Power & Gas, Fluor Enterprises, Samsung C&T Corporation and NuScale Power have signed a memorandum of understanding (MoU) to collaborate to implement NuScale small modular reactor plants (SMR) in Romania and elsewhere in Central and Eastern Europe.

Date: Thursday, 15 June 2023
Original article: world-nuclear-news.org/Articles/Nuclearelectrica-and-partners-sign-MoU-for-NuScale

"A new clean energy economy is emerging - and emerging much faster than many realise," International Energy Agency (IEA) Executive Director Fatih Birol said at the launch of the agency's eighth World Energy Investment report.

Date: Wednesday, 31 May 2023
Original article: neimagazine.com/news/newsiea-report-on-clean-energy-investments-says-little-about-nuclear-10897991

US-based NuScale Power has joined the Romanian Atomic Forum (Romatom) as a supporting member to champion the association’s nuclear energy goals. Romania aims to be the first country in Europe to deploy a NuScale VOYGR small modular reactor (SMR) power plant. John Hopkins, NuScale President & CEO, said NuScale was “committed to advancing the secure deployment of SMRs globally”.

Date: Friday, 26 May 2023
Original article: neimagazine.com/news/newsnuscale-power-joins-romanian-atomic-forum-10884712

Funding of up to USD275 million to advance the deployment of a NuScale Power Corporation VOYGR small modular reactor (SMR) plant in Romania was announced at the G7 leaders' summit by the USA and "multinational public-private partners" from Japan, South Korea and the United Arab Emirates.

Date: Tuesday, 23 May 2023
Original article: world-nuclear-news.org/Articles/NuScale-s-Romanian-SMR-plan-gets-USD275-million-bo

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

Data from Swiss Nuclear Forum shows five units were shut down Leibstadt, one of Switzerland's four nuclear power units in commercial operation. Image courtesy Alpiq. There were 438 commercial nuclear power plants in operation in 33 countries at the end of 2022, according to data from the Swiss Nuclear Forum.

The forum said six new nuclear power plants went online in 2022 and five units were permanently shut down.

The six new plants were Olkiluoto-3 in Finland, the first new reactor to start up in Western Europe in around 15 years, Fuqing-6 and Hongyanhe-6 in China, Kanupp-3 in Pakistan, Shin-Hanul-1 in South Korea and Barakah-3 in the United Arab Emirates.

Date: Tuesday, 14 February 2023
Original article: nucnet.org/news/438-reactors-in-operation-with-six-new-units-online-in-2022-2-1-2023